Suchergebnisse - "Galler, Martin"

PubPharm (13)

1

A Peroxiredoxin-P38 MAPK scaffold increases MAPK activity by MAP3K-independent mechanisms

enthalten in: bioRxiv.org | 2024

von Cao, M. | Day, A. | Galler, M. | +6

2

Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia

enthalten in: Leukemia | 2024

von Bell, H. | Blair, H. | Jepson Gosling, S. | +8

3

Excessive vincristine exposure in a child being treated for acute lymphoblastic leukaemia with underlying Dubin-Johnson syndrome : a case report

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Barnett, S. | Nyein, A. | Galler, M. | +4

4

A peroxiredoxin-P38 MAPK scaffold increases MAPK activity by MAP3K-independent mechanisms

enthalten in: Molecular cell | 2023

von Cao, M. | Day, A. | Galler, M. | +9

5

Excessive vincristine exposure in a child being treated for acute lymphoblastic leukaemia with underlying Dubin–Johnson syndrome: a case report

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Barnett, S. | Nyein, A. | Galler, M. | +4

6

Excessive vincristine exposure in a child being treated for acute lymphoblastic leukaemia with underlying Dubin–Johnson syndrome: a case report

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Barnett, S. | Nyein, A. | Galler, M. | +4

7

Excessive vincristine exposure in a child being treated for acute lymphoblastic leukaemia with underlying Dubin–Johnson syndrome: a case report

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Barnett, S. | Nyein, A. | Galler, M. | +4

8

HDAC6 regulates NF-κB signalling to control chondrocyte IL-1-induced MMP and inflammatory gene expression

enthalten in: Scientific reports | 2022

von Barter, M. | Butcher, A. | Wang, H. | +6

9

Aurora A regulation by reversible cysteine oxidation reveals evolutionarily conserved redox control of Ser/Thr protein kinase activity

enthalten in: Science signaling | 2020

von Byrne, D. | Shrestha, S. | Galler, M. | +7

10

PARP inhibitor rucaparib induces changes in NAD levels in cells and liver tissues as assessed by MRS

enthalten in: NMR in biomedicine | 2017

von Almeida, G. | Bawn, C. | Galler, M. | +6